Wellgistics Health (NASDAQ:MEDS) Releases Earnings Results

Wellgistics Health (NASDAQ:MEDS) issued its earnings results on Friday. The company reported ($1.18) earnings per share for the quarter, Zacks reports.

Wellgistics Health Trading Down 23.0%

MEDS stock traded down $0.20 on Friday, hitting $0.67. 5,686,267 shares of the company’s stock traded hands, compared to its average volume of 2,175,329. Wellgistics Health has a 1-year low of $0.55 and a 1-year high of $35.50. The stock has a market cap of $2.14 million, a price-to-earnings ratio of -0.01 and a beta of -3.14. The stock has a fifty day moving average of $2.48 and a 200-day moving average of $5.16.

Analyst Ratings Changes

Several equities research analysts have weighed in on MEDS shares. Wall Street Zen lowered Wellgistics Health to a “strong sell” rating in a research report on Saturday, October 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of Wellgistics Health in a report on Monday, September 21st. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock has a consensus rating of “Sell”.

About Wellgistics Health

Wellgistics Health, Inc. (NASDAQ: MEDS) is a healthcare technology and pharmaceutical services company focused on improving access to prescription medications. Through its platform and related services, the company connects pharmaceutical manufacturers, wholesalers, healthcare providers, pharmacies and patients within the prescription-drug supply chain. The company provides technology and logistical solutions intended to support medication ordering, distribution and fulfillment. Its offerings are designed to help independent pharmacies and other healthcare participants manage prescription access, streamline supply-chain processes and serve patients more efficiently.